1. Radix Astragali and Its Representative Extracts for Diabetic Nephropathy: Efficacy and Molecular Mechanism
   Hui-zhong Xue et al, 2024, Journal of Diabetes Research CrossRef
2. Noncoding RNAs in Diabetic Nephropathy: Pathogenesis, Biomarkers, and Therapy
   Jiarong Lv et al, 2020, Journal of Diabetes Research CrossRef
3. The Effect of Terpenoid Natural Chinese Medicine Molecular Compound on Lung Cancer Treatment
   Heng Sun et al, 2021, Evidence-Based Complementary and Alternative Medicine CrossRef
4. Astragaloside IV attenuates high glucose‐induced NF‐κB‐mediated inflammation through activation of PI3K/AKT‐ERK‐dependent Nrf2/ARE signaling pathway in glomerular mesangial cells
   Xue Su et al, 2023, Phytotherapy Research CrossRef
5. Based on Network Pharmacology and Molecular Docking to Explore the Underlying Mechanism of Huangqi Gegen Decoction for Treating Diabetic Nephropathy
   Shanshan Ding et al, 2021, Evidence-Based Complementary and Alternative Medicine CrossRef
6. Preclinical Investigations on Anti-fibrotic Potential of Long-Term Oral Therapy of Sodium Astragalosidate in Animal Models of Cardiac and Renal Fibrosis
   Xiao-Yi Chen et al, 2024, ACS Pharmacology & Translational Science CrossRef
7. Serum exosomal miR-192 serves as a potential detective biomarker for early pregnancy screening in sows
   Ruonan Gao et al, 2023, Animal Bioscience CrossRef
8. Fufang shenhua tablet, astragali radix and its active component astragaloside IV: Research progress on anti-inflammatory and immunomodulatory mechanisms in the kidney
   Run Li et al, 2023, Frontiers in Pharmacology CrossRef
9. Heidihuangwan alleviates renal fibrosis in rats with 5/6 nephrectomy by inhibiting autophagy
   Ying-Ying Li et al, 2022, Frontiers in Pharmacology CrossRef
10. Roles of microRNA-192 in diabetic nephropathy: the clinical applications and mechanisms of action
    Xiaoqing Wan et al, 2023, Frontiers in Endocrinology CrossRef
11. Underlying mechanisms and molecular targets of genistein in the management of type 2 diabetes mellitus and related complications
    Tao Jiang et al, 2024, Critical Reviews in Food Science and Nutrition CrossRef
12. Astragalus and its formulas as a therapeutic option for fibrotic diseases: Pharmacology and mechanisms
    Yi Zhu et al, 2022, Frontiers in Pharmacology CrossRef
13. To Develop Biomarkers for Diabetic Nephropathy Based on Genes Related to Fibrosis and Propionate Metabolism and Their Functional Validation
    Sha Li et al, 2024, Journal of Diabetes Research CrossRef
14. FOXO3a Protects against Kidney Injury in Type II Diabetic Nephropathy by Promoting Sirt6 Expression and Inhibiting Smad3 Acetylation
    Xiaowei Wang et al, 2021, Oxidative Medicine and Cellular Longevity CrossRef